ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
8.95
+0.34 (3.95%)
At close: Jul 2, 2026, 4:00 PM EDT
9.03
+0.08 (0.88%)
After-hours: Jul 2, 2026, 7:45 PM EDT
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $2.07 billion as of July 2, 2026. Its market cap has decreased by -54.00% in one year.
Market Cap
2.07B
Enterprise Value
2.14B
1-Year Change
-54.00%
Ranking
Category
Stock Price
$8.95
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $2.07B, an increase of 4,032.20%. That is a compound annual growth rate of 34.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.07B | -52.21% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 2.14B |
| Ocular Therapeutix | 2.11B |
| Palvella Therapeutics | 2.10B |
| Taysha Gene Therapies | 2.09B |
| Monte Rosa Therapeutics | 2.05B |
| Stoke Therapeutics | 2.04B |
| Sarepta Therapeutics | 2.04B |
| Lakefront Biotherapeutics NV | 2.03B |